# Presenter Script - M.Pharm Proposal Presentation
## Evaluation of a Novel Polyherbal Formulation for Neuroprotection in Diabetes-Associated Cognitive Impairment

**Presenter:** Najma Shaikh  
**Guide:** Dr. Digambar Ambikar  
**Institution:** SCES's Indira College of Pharmacy, Pune  
**Target Duration:** ~30 minutes

---

# ðŸŽ¯ ANALOGY GUIDE: THE WEDDING BUFFET

Throughout this presentation, we'll use a **Wedding Buffet** analogy to explain complex scientific concepts:

| Scientific Concept | Wedding Buffet Analogy |
|-------------------|------------------------|
| **Brain cells (neurons)** | Wedding guests waiting for food |
| **Glucose (brain fuel)** | Delicious food at the buffet |
| **Insulin** | Caterers who serve food to guests |
| **Insulin resistance** | Caterers go on strike - no one to serve |
| **Oxidative stress** | Food piles up, starts rotting |
| **Neuroinflammation** | VIP guests start bad-mouthing: *"What kind of wedding is this? Why invite us if you can't serve?"* |
| **Cognitive decline** | The whole wedding is ruined - reputation damaged |
| **Polyherbal formulation** | Rescue team: New caterers (Jamun), Cleaners (Barleria), Event managers (Brahmi) |

---

# SLIDE 1: TITLE SLIDE
**â±ï¸ Duration: 1 minute**

> *[Display title slide with project details]*

### Script:

Good morning respected Chairperson, esteemed faculty members, and my dear colleagues.

My name is **Najma Shaikh**, M.Pharm 2nd year student from the Department of Pharmacology. 

Today, I am honored to present my research proposal titled:

**"Evaluation of a Novel Polyherbal Formulation containing *Syzygium cumini*, *Bacopa monnieri*, and *Barleria cristata* for Neuroprotection in Diabetes-Associated Cognitive Impairment in Mice"**

This work is being carried out under the expert guidance of **Dr. Digambar Ambikar**, Associate Professor, Department of Pharmacology.

---

# SLIDE 2: CONTENT OVERVIEW
**â±ï¸ Duration: 30 seconds**

> *[Display table of contents]*

### Script:

Before we dive in, let me give you a quick roadmap of what we'll cover today:

We'll start with the **Introduction** - understanding the problem. Then move to **Literature Review** - what research says. We'll explore our three medicinal plants in the **Plant Profile** section.

Next, we'll discuss **Need of Work** - why this study matters, followed by our **Research Hypothesis**, and clear **Aims & Objectives**.

The **Plan of Work** and **Materials & Methods** will show you exactly how we'll conduct this study. We'll look at **Evaluation Parameters** - what we'll measure, and **Expected Outcomes** - what we anticipate finding.

Finally, I'll share our **Work Till Date** - what we've accomplished so far, and close with our **References**.

Let's begin!

---

# SLIDE 3: INTRODUCTION (Section Divider)
**â±ï¸ Duration: 15 seconds**

> *[Display Introduction divider with brain imagery]*

### Script:

So let's start with the foundation - Understanding the problem we're trying to solve.

*[Transition to next slide]*

---

# SLIDE 4: BACKGROUND - THE WEDDING BUFFET ANALOGY
**â±ï¸ Duration: 2.5 minutes**

> *[Display the Wedding Buffet analogy visual with scientific correlation]*

### Script:

To help everyone understand this complex topic, let me share a simple analogy - imagine a **Grand Wedding Buffet**.

*[Point to the buffet image]*

Picture this: It's a beautiful wedding celebration. The buffet is loaded with the most delicious food you've ever seen - biryani, paneer dishes, sweets - everything! The guests are hungry and excited.

But here's the problem: **The caterers have gone on strike!**

*[Point to "Plenty of food... but no one to serve!"]*

There's plenty of food, but nobody to serve it to the guests. What happens next?

**FIRST** - *[Point to Food piles up and rots]* - The food starts piling up and rotting. In our body, this is called **Oxidative Stress**. When insulin isn't working properly (insulin resistance), glucose can't enter brain cells. It builds up in the blood and starts causing damage - just like rotting food creates a mess.

**SECOND** - *[Point to VIP guests bad-mouthing]* - Now imagine the VIP guests getting frustrated. They start bad-mouthing the wedding: 

*"What kind of wedding is this?"*
*"Why did they even invite us if they can't serve us?"*
*"I'm never coming to their functions again!"*

This negativity spreads throughout the venue. In our body, this is **Neuroinflammation** - inflammatory molecules like TNF-alpha and Interleukins start spreading toxic signals throughout the brain.

**FINALLY** - *[Point to Whole party is ruined]* - The entire wedding is ruined. The reputation is damaged. Years of planning, wasted! 

In the brain, this is **Cognitive Decline** - memory problems, difficulty learning, confusion.

*[Point to Polyherbal Rescue Team]*

But what if we could send in a **Rescue Team**? That's exactly what our polyherbal formulation aims to do - and we'll see how each plant plays a unique role in this rescue mission.

**The Scientific Link:** When the brain becomes insulin-resistant, neurons starve, toxic waste builds up, and cognitive decline begins. Our study addresses exactly this problem.

---

# SLIDE 5: GLOBAL DIABETIC EPIDEMIC
**â±ï¸ Duration: 1 minute**

> *[Display statistics with growth projection graph]*

### Script:

Now, let's see why this problem demands urgent attention.

Look at these numbers - they tell a concerning story.

*[Point to 2025 projection]*

As of 2025, approximately **537 million adults** worldwide are living with diabetes.

*[Point to 2045 projection]*

By 2045 - just 20 years from now - this number is expected to rise to **783 million**. That's nearly a 46% increase!

*[Point to Diabetes Share box]*

Here's what's particularly relevant to our study:
- **Type 2 Diabetes** accounts for **90%** of all diabetes cases
- **India ranks #2** globally in diabetic population

This isn't just about numbers - these are real people, many of whom will develop brain complications that affect their memory, thinking, and quality of life.

---

# SLIDE 6: BEYOND GLUCOSE - DIABETIC COMPLICATIONS
**â±ï¸ Duration: 1 minute**

> *[Display complications table]*

### Script:

Most people think of diabetes as just a "sugar problem." But the reality is far more complex.

*[Point to the table]*

Look at the range of complications:

- **Cardiovascular disease** - 2 to 4 times higher risk
- **Retinopathy** - affecting 30-40% of diabetics, potentially causing blindness
- **Nephropathy** - 20-40% develop chronic kidney disease
- **Neuropathy** - 50% develop nerve damage

But here's what caught our attention for this research:

*[Emphasize the last row]*

**Cognitive Impairment** - More than **60% of diabetic patients** show some level of cognitive deficit!

This is not just minor forgetfulness. We're talking about significant problems with memory, attention, and decision-making. Yet, this complication receives far less attention than others.

This is the gap our research aims to address.

---

# SLIDE 7: THE DIABETES-BRAIN CONNECTION
**â±ï¸ Duration: 1.5 minutes**

> *[Display the pathway flowchart showing Hyperglycemia â†’ Cognitive Decline]*

### Script:

Let me walk you through the scientific pathway - how diabetes actually damages the brain.

*[Trace the pathway on the slide]*

It starts with **Chronic Hyperglycemia** - persistently high blood sugar levels.

This leads to **Impaired Brain Insulin Signaling**. The IRS-1/PI3K/Akt pathway - which is essentially the brain's "key" for letting glucose in - stops working properly. 

Remember our analogy? The caterers are on strike!

*[Point to Oxidative Stress box]*

Next comes **Oxidative Stress**:
- ROS (Reactive Oxygen Species) â†‘ increase
- MDA (a marker of lipid damage) â†‘ increases
- SOD, CAT, GSH (our natural antioxidants) â†“ decrease

The food is rotting!

*[Point to Neuroinflammation box]*

Then **Neuroinflammation** kicks in:
- TNF-Î± â†‘ increases
- IL-1Î² â†‘ increases  
- IL-6 â†‘ increases
- NF-ÎºB pathway activates

The VIP guests are now actively bad-mouthing, spreading negativity!

*[Point to Synaptic Dysfunction]*

This leads to **Synaptic Dysfunction**:
- BDNF â†“ decreases (brain's growth factor)
- LTP impaired (learning mechanism)
- Hippocampus gets damaged (memory center)

*[Point to Cognitive Decline]*

The end result? **COGNITIVE DECLINE** - the wedding is completely ruined.

---

# SLIDE 8: DAMAGE TIMELINE
**â±ï¸ Duration: 45 seconds**

> *[Display timeline showing progression: Days â†’ Weeks â†’ Months]*

### Script:

What's particularly concerning is how quickly this damage progresses.

*[Point to each stage]*

**Within Days:** Blood-brain barrier starts breaking down, and inflammation begins. Think of it as the first complaints starting at the wedding.

**Within Weeks:** Synaptic loss occurs. The connections between brain cells - which are essential for learning and memory - start dying. The negativity is spreading.

**Within Months:** Cognitive impairment becomes clinically evident. By this time, significant damage has already occurred. The reputation is permanently damaged.

This timeline emphasizes why **early intervention** with neuroprotective agents is crucial.

---

# SLIDE 9: LITERATURE REVIEW (Section Divider)
**â±ï¸ Duration: 10 seconds**

> *[Display Literature Review divider]*

### Script:

Now, let's look at what existing research tells us about this problem and potential solutions.

*[Transition to next slide]*

---

# SLIDES 10-11: LITERATURE REVIEW TABLE
**â±ï¸ Duration: 2 minutes (for both slides)**

> *[Display comprehensive literature table]*

### Script:

We conducted an extensive literature survey, and I'll highlight the key findings.

*[Point to relevant rows]*

**First**, multiple narrative and systematic reviews confirm the link between hyperglycemia, oxidative stress, and cognitive decline. Studies by Uddin et al. and Yan B et al. established that diabetes directly impacts cognitive function through AGE-RAGE pathways and mitochondrial ROS.

**Second**, preclinical studies using HFD (high-fat diet) models in mice show that:
- Diet-induced insulin resistance causes hippocampal damage
- This leads to synaptic plasticity disruption
- Memory deficits are measurable within 4-7 weeks

*[Point to intervention studies]*

**Third**, and most importantly for our work - plant-based interventions show promising results:
- Natural compounds counteract oxidative stress
- Phytoconstituents regulate antioxidant enzymes
- Multi-mechanistic approaches work better than single targets

Key takeaway: **No single study has combined Syzygium cumini, Bacopa monnieri, AND Barleria cristata** for diabetes-related cognitive protection. This is our unique contribution.

---

# SLIDE 12: PLANT PROFILE - JAMUN (Syzygium cumini)
**â±ï¸ Duration: 1.5 minutes**

> *[Display Jamun plant profile with image and properties table]*

### Script:

Let me introduce our first rescue team member - **Jamun**, scientifically known as *Syzygium cumini*.

*[Point to the image]*

This beautiful purple fruit is native to India and has been used in traditional medicine for centuries.

*[Point to key information]*

**Family:** Myrtaceae
**Parts Used:** Seeds - which are usually discarded!

**Key Constituents:** 
- Flavonoids
- Anthocyanins (responsible for the purple color)

*[Point to Evidence box]*

**What the evidence shows:**
- â†“ Reduces glucose by approximately 54%
- â†‘ Increases antioxidant capacity

**In our wedding analogy:** Jamun is like the **new team of caterers** we hire to replace the striking ones. It helps restore glucose handling - making sure the "food" (glucose) reaches the "guests" (neurons) properly.

The references by Vasi & Austin (2009) and Gani et al. (2019) support these antidiabetic and antioxidant activities.

---

# SLIDE 13: PLANT PROFILE - BRAHMI (Bacopa monnieri)
**â±ï¸ Duration: 1.5 minutes**

> *[Display Brahmi plant profile with image and properties table]*

### Script:

Our second rescue team member is **Brahmi** - *Bacopa monnieri*.

*[Point to the image]*

This small, creeping herb with white flowers has been a cornerstone of Ayurvedic medicine, especially for brain health.

**Family:** Plantaginaceae
**Parts Used:** Leaves and aerial parts

**Key Constituents:**
- Bacosides A & B - the primary active compounds
- Bacopasaponins

*[Point to Evidence box]*

**Pharmacological Evidence:**
- â†“ Decreases acetylcholinesterase (AChE) - this means more acetylcholine for memory
- â†‘ Increases BDNF - the brain's growth and repair factor
- Strong nootropic (memory-enhancing) and antioxidant properties

**In our wedding analogy:** Brahmi is the **Event Manager** we bring in. While others are fixing the immediate problems, Brahmi works on restoring the reputation of the wedding. It helps rebuild and strengthen the neural connections - essentially managing the long-term recovery of the celebration.

Reference: Helmi et al., 2021

---

# SLIDE 14: PLANT PROFILE - BARLERIA CRISTATA
**â±ï¸ Duration: 1.5 minutes**

> *[Display Barleria cristata profile with purple flower image]*

### Script:

Our third and most novel rescue team member is **Barleria cristata** - a beautiful purple-flowered plant.

*[Point to the image]*

This is particularly exciting because it's a **less-studied plant** - adding novelty to our formulation.

**Family:** Acanthaceae
**Parts Used:** Leaves

**Key Constituents:**
- Iridoid glycosides
- Flavonoids

*[Point to Evidence box]*

**Key Activity:** 
- Strong **Neuroprotective** potential
- Anti-inflammatory properties
- Antioxidant effects

*[Point to Novelty Note]*

**Why this is special:** Being a less-studied plant, including Barleria cristata adds **formulation novelty** to our research. We're not just repeating what others have done - we're exploring new territory.

**In our wedding analogy:** Barleria cristata is the **Cleanup Crew**. While Jamun fixes the service and Brahmi manages the event, Barleria goes around calming down the angry VIP guests - stopping the bad-mouthing, reducing the inflammation and toxic gossip spreading through the venue.

---

# SLIDE 15: NEED OF WORK (Section Divider)
**â±ï¸ Duration: 10 seconds**

> *[Display Need of Work divider]*

### Script:

Now that we understand the problem and our potential solution, let's discuss why this research is needed.

---

# SLIDE 16: RESEARCH GAP
**â±ï¸ Duration: 1 minute**

> *[Display 3 research gaps in ascending pathway]*

### Script:

Through our literature review, we identified **three critical gaps**:

*[Point to Gap 1]*

**Gap 1: Incomplete Treatment Approach**
Current antidiabetic drugs control blood sugar but do NOT protect the brain. It's like treating the symptom while ignoring the root cause of damage.

*[Point to Gap 2]*

**Gap 2: Limited Integrated Studies**
Most research focuses on single plants or single pathways. But diabetes-related brain damage involves MULTIPLE pathways - oxidative stress, inflammation, AND metabolic dysfunction. We need integrated solutions.

*[Point to Gap 3]*

**Gap 3: Untapped Polyherbal Potential**
While individual plants show promise, the **synergistic combination** of Syzygium + Bacopa + Barleria has NEVER been studied for neuroprotection in diabetes. This is virgin territory for research.

---

# SLIDE 17: TREATMENT LIMITATIONS
**â±ï¸ Duration: 1 minute**

> *[Display current therapy vs treatment gap vs phytotherapy promise]*

### Script:

Let's visualize the current treatment landscape.

*[Point to Current Antidiabetic Therapy]*

**Current Situation:**
Metformin, Sulfonylureas, SGLT2 inhibitors - they're effective for blood glucose control. âœ“

*[Point to Treatment Gap]*

**The Problem:**
Glucose control â‰  Brain protection!

These drugs offer:
- Limited protection against neurodegeneration
- Few drugs specifically target cognitive decline in diabetes

It's like hiring caterers who can cook food but refuse to serve it!

*[Point to Phytotherapy Promise]*

**The Solution - Phytotherapy:**
- Multi-mechanistic action
- Antioxidant + Anti-inflammatory + Neuroprotective
- Better tolerability

*[Point to bottom banner]*

**THE NEED:** Multi-target neuroprotective strategies - which is exactly what our polyherbal formulation provides!

---

# SLIDE 18: WHAT THIS STUDY ADDRESSES
**â±ï¸ Duration: 1 minute**

> *[Display gaps and solutions table]*

### Script:

Let me show you exactly how our study fills each gap:

*[Point to each row]*

**Gap: Lack of brain-targeted therapy**
â†’ **Our Solution:** Polyherbal formulation with proven neuroprotective herbs

**Gap: Single-outcome studies**
â†’ **Our Solution:** Integrated behavioral + biochemical + histological assessment

**Gap: High cost of treatment**
â†’ **Our Solution:** Affordable phytotherapy approach using locally available plants

**Gap: Novel combination validation**
â†’ **Our Solution:** FIRST study on Syzygium + Bacopa + Barleria combination

*[Point to bottom banner]*

We're not just proposing theory - we have **practical strategies** backed by a comprehensive evaluation plan.

---

# SLIDE 19: RESEARCH HYPOTHESIS
**â±ï¸ Duration: 1 minute**

> *[Display 3 hypothesis cards]*

### Script:

Based on our literature review and identified gaps, we propose **three testable hypotheses**:

*[Point to H1]*

**Hypothesis 1 - Disease Model:**
High-fat diet combined with fructose administration will successfully induce metabolic dysfunction and cognitive impairment in mice - creating our disease model.

*[Point to H2]*

**Hypothesis 2 - Treatment:**
A standardized polyherbal formulation in 1:1:1 ratio of our three plants will show protective effects against this cognitive impairment.

*[Point to H3]*

**Hypothesis 3 - Correlation:**
The cognitive benefits we observe will positively correlate with improvements in metabolic and oxidative stress markers.

In other words - when the wedding service improves, the bad-mouthing should decrease, and the overall wedding experience should get better!

---

# SLIDE 20: AIM AND OBJECTIVES
**â±ï¸ Duration: 1 minute**

> *[Display Aim with 4 numbered objectives]*

### Script:

*[Point to Aim]*

**Our Aim:** To develop and evaluate a polyherbal formulation for protection against diabetes-associated cognitive impairment in an established rodent model.

*[Point to objectives]*

To achieve this, we have **four clear objectives:**

**Objective 1:** To prepare individual plant extracts and make the final polyherbal formulation in 1:1:1 ratio.

**Objective 2:** To develop the HFD + fructose model that creates metabolic problems with memory and brain changes in animals.

**Objective 3:** To check learning, memory, anxiety, and movement using simple behavior tests - NOR, EPM, and OFT - and measure metabolic changes like glucose and lipid profile.

**Objective 4:** To confirm brain protection by measuring oxidative stress markers, inflammation, and examining hippocampus tissue under the microscope.

---

# SLIDE 21: WHY THIS PLANT COMBINATION?
**â±ï¸ Duration: 1.5 minutes**

> *[Display flowchart showing each plant's contribution to final outcome]*

### Script:

Now, you might wonder - why specifically THESE three plants?

*[Point to the flowchart]*

Let me show you how each plant contributes uniquely:

*[Point to Syzygium cumini]*
**Syzygium cumini (Jamun):**
- â†“ Glucose
- â†‘ Insulin sensitivity
- â†‘ Antioxidant capacity

This is our **metabolic controller** - fixing the glucose handling.

*[Point to Bacopa monnieri]*
**Bacopa monnieri (Brahmi):**
- â†‘ Memory enhancement
- â†“ Acetylcholinesterase
- â†‘ BDNF levels

This is our **cognitive enhancer** - rebuilding brain function.

*[Point to Barleria cristata]*
**Barleria cristata:**
- â†“ Inflammation
- â†“ NF-ÎºB pathway
- â†‘ Neuroprotection

This is our **anti-inflammatory shield** - calming the toxic response.

*[Point to Combination Outcome]*

**Together, they provide:**
- Metabolic control
- Cognitive protection
- Neuronal preservation

It's like sending in a complete rescue team - caterers, event managers, AND cleanup crew - instead of just one person trying to fix everything!

---

# SLIDE 22: PLAN OF WORK
**â±ï¸ Duration: 1.5 minutes**

> *[Display comprehensive workflow flowchart]*

### Script:

Let me walk you through our complete plan of work.

*[Trace the flowchart]*

We start with **Literature Survey** - which is largely complete.

Then **Procurement & Authentication** of plant materials - getting our plants verified by Botanical Survey of India.

Next, **Extraction â†’ Formulation â†’ Preliminary Standardization** - preparing our polyherbal extract.

Meanwhile, we're also doing **Network Pharmacology** analysis - using computational tools to identify:
- Phytoconstituent genes (what our plant compounds target)
- Disease genes (what goes wrong in diabetes + cognitive impairment)
- Common gene identification (where they overlap)

*[Point to Animal Experimentation box]*

The main phase is **Complete Animal Experimentation** over 60 days total:
- Acclimatization
- Model induction with HFD + Fructose
- Treatment phase
- Behavioral tests
- Sacrifice and tissue collection
- Histopathology processing

*[Point to analysis boxes]*

Finally, we conduct:
- **Biochemical assays** on blood and brain tissue
- **Histopathology analysis** of hippocampus
- **Statistical analysis** and data interpretation

---

# SLIDE 23: MATERIAL AND METHOD (Section Divider)
**â±ï¸ Duration: 10 seconds**

> *[Display Material and Method section divider]*

### Script:

Now let me detail our materials and methods - the technical backbone of this study.

---

# SLIDE 24: ANIMAL MODEL
**â±ï¸ Duration: 1 minute**

> *[Display Swiss Albino Mice specifications with mouse image]*

### Script:

For our study, we're using **Swiss Albino Mice**.

*[Point to Specifications]*

**Animal Specifications:**
- Age: 4-6 weeks
- Weight: Approximately 20-25 grams
- Sex: Male (to avoid hormonal cycle variations)
- Source: Registered breeder

*[Point to Housing conditions]*

**Housing Conditions:**
- Temperature: 22 Â± 2Â°C
- Humidity: 30-70%
- Light cycle: 12 hours light/12 hours dark
- Bedding: Standard laboratory grade

*[Point to Ethical section]*

**Ethical Compliance:**
- Following CCSEA guidelines
- IAEC approval is mandatory before any animal work
- All protocols designed to minimize distress

These standardized conditions ensure our results are reliable and reproducible.

---

# SLIDE 25: EXTRACTION METHOD
**â±ï¸ Duration: 1.5 minutes**

> *[Display 3-phase extraction process: Pre-Processing â†’ Dual Maceration â†’ Concentrate]*

### Script:

Let me explain how we'll prepare our polyherbal extract.

*[Point to Pre-Processing]*

**Phase 1 - Pre-Processing:**
- Plants collected in 1:1:1 ratio - equal parts of Syzygium cumini (seeds), Bacopa monnieri (leaves), and Barleria cristata (leaves)
- Materials are dried and ground into fine powder

*[Point to Dual Maceration]*

**Phase 2 - Dual Maceration:**
This is our extraction technique:
- Mix powder with 70% ethanol (hydro-alcoholic extraction)
- **First maceration:** 72 hours with occasional stirring
- Filter and collect the filtrate
- Take the remaining marc (leftover material)
- **Second maceration:** 48 hours more
- Pool both filtrates together

This dual extraction ensures maximum recovery of bioactive compounds.

*[Point to Concentrate]*

**Phase 3 - Concentration:**
- Concentrate at temperature below 50Â°C (to preserve heat-sensitive compounds)
- Dry at below 40Â°C
- Store in airtight containers

This gives us our final polyherbal extract ready for formulation.

---

# SLIDE 26: PRELIMINARY PHYTOCHEMICAL SCREENING
**â±ï¸ Duration: 45 seconds**

> *[Display screening parameters in rounded boxes]*

### Script:

Before we proceed to animal studies, we'll confirm what's actually in our extract.

*[Point to each parameter]*

**We'll test for:**
- **Phenolics** - important antioxidants
- **Flavonoids** - protect against oxidative stress
- **Terpenoids** - anti-inflammatory compounds
- **Alkaloids** - various pharmacological activities
- **Saponins** - membrane-active compounds

These qualitative tests confirm the presence of bioactive compound classes expected from our three plants.

---

# SLIDE 27: CHEMICALS AND REAGENTS
**â±ï¸ Duration: 30 seconds**

> *[Display list of chemicals and reagents]*

### Script:

For our study, we'll use:

- **Ethanol 70%** for hydro-alcoholic extraction
- **Petroleum ether** for defatting
- **Distilled water** 
- **Glucose estimation** supplies - glucometer and strips
- **Metformin 100 mg/kg** as Standard A
- **Panax ginseng powder 100 mg/kg** as Standard B
- **Metformin + Panax ginseng combination** as Standard C

All chemicals will be analytical grade from reputed suppliers.

---

# SLIDE 28: DISEASE MODEL INDUCTION
**â±ï¸ Duration: 1.5 minutes**

> *[Display HFD pellet recipe and preparation flowchart]*

### Script:

This is a crucial slide - how we'll create our disease model.

*[Point to HFD Pellet Recipe]*

**Self-Prepared HFD Pellets (per 100g):**
- Normal pellet base: 33g
- Corn starch: 15g
- Maida: 15g
- Groundnuts: 20g
- Vanaspati ghee: 10g
- Coconut oil: 5g
- Sugar: 2g

This formulation provides approximately **60% calories from fat** - mimicking Western-style unhealthy diet.

*[Point to Preparation flowchart]*

**Preparation Steps:**
Dry Mix â†’ Add Oils â†’ Knead â†’ Pelletize â†’ Dry â†’ Store

Plus, we'll add **10% fructose in drinking water** to accelerate metabolic dysfunction.

*[Point to Model Confirmation]*

**How we'll confirm the model is working:**
- â†‘ Fasting Blood Glucose
- â†‘ Body Weight
- â†‘ HbA1C
- Impaired Cognitive Tests

This combination of HFD + Fructose reliably produces insulin resistance and cognitive deficits within 4-5 weeks.

---

# SLIDE 29: EXPERIMENTAL GROUPS
**â±ï¸ Duration: 1 minute**

> *[Display 8-group experimental design table]*

### Script:

We have designed a comprehensive **8-group study** with 6 animals per group - total 48 animals.

*[Point to each group]*

**Group I - Normal Control:** Normal diet + vehicle only. Our healthy baseline.

**Group II - Disease Control:** HFD + 10% fructose, no treatment. Shows full disease progression.

**Group III - Standard A:** Metformin 100 mg/kg - the gold standard antidiabetic.

**Group IV - Standard B:** Panax ginseng 100 mg/kg - natural cognitive enhancer.

**Group V - Standard C:** Metformin + Panax ginseng combination.

**Groups VI, VII, VIII - Test Groups:**
- Test LD (Low Dose): Polyherbal 100 mg/kg
- Test MD (Medium Dose): Polyherbal 200 mg/kg
- Test HD (High Dose): Polyherbal 400 mg/kg

This dose range allows us to establish dose-response relationship.

---

# SLIDE 30: STUDY TIMELINE
**â±ï¸ Duration: 1 minute**

> *[Display Gantt-style timeline with monitoring schedule]*

### Script:

Here's our complete study timeline:

*[Point to timeline bar]*

**Week 0:** 7 days of Acclimatization - animals adjust to laboratory conditions.

**Weeks 1-4:** 28 days of HFD Induction - creating the disease model.

**Weeks 5-7:** 21 days of Treatment + Testing phase.

**Week 7 End:** Sacrifice and analysis.

*[Point to FBG Monitoring Schedule]*

**Fasting Blood Glucose Monitoring:**
We'll measure at Day 0 (baseline), Day 7, Day 14, and Day 21 - tracking metabolic changes throughout treatment.

*[Point to Behavioral Test Schedule]*

**Behavioral Tests:**
- Day 18: Open Field Test (OFT)
- Day 19: Elevated Plus Maze (EPM)
- Day 20: NOR Training
- Day 21: NOR Test + Sacrifice + Tissue collection

This schedule ensures we capture the complete progression and treatment effects.

---

# SLIDE 31: EVALUATION PARAMETERS (Section Divider)
**â±ï¸ Duration: 10 seconds**

> *[Display Evaluation Parameters divider]*

### Script:

Now let's discuss what exactly we'll be measuring to evaluate our formulation's effects.

---

# SLIDE 32: EVALUATION PARAMETERS OVERVIEW
**â±ï¸ Duration: 1 minute**

> *[Display hierarchical chart of all parameters]*

### Script:

Our evaluation covers **four major domains**:

*[Point to each category]*

**1. Behavioral Assessment:**
- Novel Object Recognition (NOR) - memory
- Elevated Plus Maze (EPM) - anxiety
- Open Field Test (OFT) - locomotion and exploration

**2. Metabolic Assessment:**
- Fasting Blood Glucose
- Body Weight and Food Intake

**3. Oxidative Stress Markers:**
- MDA (damage marker)
- SOD (antioxidant enzyme)
- GSH (antioxidant molecule)
- CAT (antioxidant enzyme)

**4. Histopathology:**
- Hippocampus regions: CA1, CA3, and Dentate Gyrus

This multi-parameter approach gives us a complete picture of how our formulation works.

---

# SLIDE 33: BEHAVIORAL ASSESSMENT DETAILS
**â±ï¸ Duration: 1.5 minutes**

> *[Display 3 behavioral tests with apparatus images]*

### Script:

Let me explain each behavioral test:

*[Point to NOR]*

**Novel Object Recognition (NOR):**
This tests **recognition memory**.
- Training: Mouse explores 2 identical objects
- Test: One object replaced with a novel one
- If memory is intact, mouse spends more time with novel object
- We calculate **Discrimination Index (DI)**

*[Point to EPM]*

**Elevated Plus Maze (EPM):**
This tests **anxiety-like behavior**.
- Apparatus has open arms (scary) and closed arms (safe)
- We measure:
  - Time in open arms
  - Number of arm entries
- Anxious mice avoid open arms

*[Point to OFT]*

**Open Field Test (OFT):**
This tests **locomotion and exploration**.
- 5-minute session in an open arena
- We measure:
  - Total distance moved
  - Time in center (indicates low anxiety)
  - Rearing behavior (indicates exploration)

These tests are well-validated and give us behavioral biomarkers of cognitive function.

---

# SLIDE 34: METABOLIC ASSESSMENT
**â±ï¸ Duration: 45 seconds**

> *[Display metabolic timeline with droplet icons]*

### Script:

Metabolic assessment tracks how our formulation affects blood glucose and body weight.

*[Point to timeline]*

**Measurement Schedule:**
- **Day 0:** Baseline (before treatment starts)
- **Day 7:** Week 1 of treatment
- **Day 14:** Week 2 of treatment
- **Day 21:** End of study (before sacrifice)

**Parameters:**
- **FBS (Fasting Blood Sugar):** Measured weekly after 12-hour fast
- **Body Weight:** Recorded weekly

Progressive decrease in FBG would indicate metabolic improvement from our formulation.

---

# SLIDE 35: OXIDATIVE STRESS MARKERS
**â±ï¸ Duration: 1 minute**

> *[Display Lipid Peroxidation vs Antioxidant Defense cards]*

### Script:

Oxidative stress assessment is critical - remember, this is the "rotting food" in our analogy.

*[Point to Lipid Peroxidation card]*

**Lipid Peroxidation:**
We measure **MDA (Malondialdehyde)** using TBARS assay.
- MDA reflects damage to cell membranes
- Higher MDA = more damage
- Our formulation should â†“ decrease MDA

*[Point to Antioxidant Defense card]*

**Antioxidant Defense:**
We measure **GSH, SOD, and CAT** - the body's natural defense system.
- These reflect the brain's capacity to fight oxidative damage
- In disease, these decrease
- Our formulation should â†‘ increase these markers

Think of it this way: MDA tells us how much "food has rotted," while GSH/SOD/CAT tells us how well the "cleanup crew" is working.

---

# SLIDE 36: HISTOPATHOLOGY
**â±ï¸ Duration: 1 minute**

> *[Display hippocampus diagram with assessment table]*

### Script:

Finally, we examine the brain tissue directly under the microscope.

*[Point to brain diagram]*

**Region of Interest:** The **Hippocampus** - specifically:
- CA1 region
- CA3 region
- Dentate Gyrus

These regions are crucial for learning and memory, and they're particularly vulnerable to oxidative stress damage.

*[Point to Assessment table]*

**What we'll evaluate:**
- **Neuronal morphology:** Normal vs shrunken vs pyknotic (dying)
- **Cell density:** Cells per field
- **Degeneration score:** 0-3 scale (none to severe)
- **Inflammatory infiltration:** 0-3 scale
- **Overall damage score:** Semi-quantitative assessment

This gives us direct visual evidence of neuroprotection - or lack thereof.

---

# SLIDE 37: SAFETY PARAMETERS
**â±ï¸ Duration: 45 seconds**

> *[Display In-Life Observations and Post-Mortem Analysis]*

### Script:

Safe research is ethical research. Here's how we ensure safety:

*[Point to In-Life Observations]*

**During the Study:**
1. **General Behavior:** Any signs of distress or toxicity
2. **Mortality:** Recording any deaths
3. **Intake:** Food and water consumption, appetite changes

*[Point to Post-Mortem Analysis]*

**After Sacrifice:**
4. **Organ Weights:** Liver, kidney, brain - abnormalities indicate toxicity
5. **Gross Examination:** Visual inspection for any organ abnormalities

These observations ensure our formulation is not causing any harm while providing benefits.

---

# SLIDE 38: EXPECTED OUTCOMES (Section Divider)
**â±ï¸ Duration: 10 seconds**

> *[Display Expected Outcomes divider]*

### Script:

Now, based on our literature review and scientific rationale, here's what we expect to find.

---

# SLIDE 39: EXPECTED OUTCOMES COMPARISON
**â±ï¸ Duration: 1.5 minutes**

> *[Display Disease Control vs Polyherbal Treatment comparison]*

### Script:

Let me compare what we expect between disease control and treated groups.

*[Point to Disease Control column]*

**Disease Control (Untreated):**
- **Metabolic:** â†‘ Body weight, â†‘ FBG, â†‘ HDL (dysfunctional)
- **Cognitive:** â†“ Discrimination Index, â†‘ Anxiety-like behavior
- **Oxidative Stress:** â†‘ MDA (more damage)
- **Histology:** Neuronal damage, pyknosis, vacuolation

This represents the "ruined wedding" - full disease progression.

*[Point to Polyherbal Formulation column]*

**Polyherbal Treatment (Groups VI-VIII):**
- **Metabolic:** â†“ FBG moving toward normal
- **Cognitive:** â†‘ Discrimination Index (better memory), normalized exploration and anxiety
- **Oxidative Stress:** â†“ MDA, â†‘ GSH/SOD/CAT (restored defense)
- **Histology:** Protected hippocampus (CA1/CA3/DG preserved)

*[Point to bottom note]*

**Dose-Response Expectation:**
We anticipate 200-400 mg/kg will show the best efficacy - with 400 mg/kg likely showing maximum effect.

---

# SLIDE 40: CONCLUSION
**â±ï¸ Duration: 1.5 minutes**

> *[Display conclusion bullet points]*

### Script:

Let me summarize the core message of this proposal.

*[Read through key points]*

**First:** Diabetes-related cognitive impairment is multi-factorial - involving metabolic dysfunction, oxidative stress, inflammation, AND neuronal damage. You can't fix it with just one approach.

**Second:** Single-target therapy gives only partial benefit - it controls sugar but doesn't fully protect brain pathways. Like fixing only one part of a broken wedding while ignoring the rest.

**Third:** Our project proposes a **team-based polyherbal strategy** in 1:1:1 ratio for multi-target coverage.

*[Emphasize each plant's role]*

**How our rescue team works:**
- **Jamun** acts as the metabolic anchor - better glycemic control, better insulin handling
- **Barleria** supports cleanup - reducing oxidative and inflammatory burden
- **Bacopa** supports cognition - strengthening memory circuits and neuronal resilience

Together, they address ALL the pathways involved in diabetes-related brain damage.

---

# SLIDE 41: WORK TILL DATE - PLANT PROCUREMENT
**â±ï¸ Duration: 1 minute**

> *[Display BSI certificate and procurement checklist]*

### Script:

Now let me share what we've accomplished so far.

*[Point to checklist]*

**Completed steps:**
âœ“ Plant materials procured for polyherbal formulation
âœ“ Parts collected: Jamun (seeds), Brahmi (leaves), Barleria (leaves)
âœ“ Samples labeled and stored appropriately
âœ“ Specimens submitted to Botanical Survey of India (BSI), Pune

*[Point to certificate]*

**Authentication:**
You can see the BSI certificate here confirming the botanical identity of our plant samples:
- Specimen 01: *Syzygium cumini* - Myrtaceae
- Specimen 02: *Bacopa monnieri* - Plantaginaceae  
- Specimen 03: *Barleria cristata* (to be confirmed)

This authentication is crucial for research validity and regulatory compliance.

---

# SLIDES 42-44: NETWORK PHARMACOLOGY
**â±ï¸ Duration: 1.5 minutes (for all 3 slides)**

> *[Display network pharmacology analysis]*

### Script:

We also conducted preliminary **Network Pharmacology** analysis - a computational approach to understand how our plants might work.

*[Point to Slide 42 - Venn diagram]*

**What we found:**
- Our three plants contain **81 unique phytoconstituents**
- After filtering through SwissADME for drug-likeness, we got **835 potential targets**
- Diabetes and cognitive diseases have **156 unique disease targets**
- Most excitingly - we found **33 common targets** - these are genes that both our plant compounds AND the diseases affect

This 3.4% overlap might seem small, but it represents 33 specific molecular targets our formulation may act on!

*[Point to Slide 43]*

After filtering for blood-brain barrier penetration and selecting disease pathways, we identified **48 phytoconstituents** that are most likely responsible for the neuroprotective effects.

*[Point to Slide 44 - Network map]*

This network visualization shows how our plant compounds interact with disease targets - the green nodes are compounds, orange nodes are gene targets. The complex interactions support our multi-target approach.

---

# SLIDES 45-49: REFERENCES
**â±ï¸ Duration: 10 seconds**

> *[Display reference slides]*

### Script:

Our proposal is supported by **66 peer-reviewed references** from journals including Diabetes Care, Lancet, Neurology, and various phytotherapy publications.

The complete reference list is available for your review.

---

# SLIDE 50: THANK YOU
**â±ï¸ Duration: 30 seconds**

> *[Display Thank You slide]*

### Script:

With this, I come to the end of my presentation.

To summarize: We're proposing to evaluate a novel polyherbal formulation containing *Syzygium cumini*, *Bacopa monnieri*, and *Barleria cristata* for its potential to protect against diabetes-associated cognitive impairment in mice.

We believe this team-based approach - addressing metabolic control, oxidative stress, and inflammation simultaneously - offers a promising strategy for a condition that affects millions worldwide.

I sincerely thank my guide **Dr. Digambar Ambikar** for his constant support and guidance, the institution for providing facilities, and all of you for your patient attention.

I am now open to your valuable questions and suggestions.

**Thank you!**

---

# ðŸ“Š TIMING SUMMARY

| Section | Slides | Duration |
|---------|--------|----------|
| Title & Content Overview | 1-2 | 1.5 min |
| Introduction | 3-8 | 7 min |
| Literature Review | 9-11 | 2 min |
| Plant Profiles | 12-14 | 4.5 min |
| Need of Work | 15-18 | 3 min |
| Hypothesis & Objectives | 19-20 | 2 min |
| Plan of Work | 21-22 | 3 min |
| Materials & Methods | 23-30 | 7.5 min |
| Evaluation Parameters | 31-37 | 6 min |
| Expected Outcomes & Conclusion | 38-40 | 3 min |
| Work Till Date | 41-44 | 2.5 min |
| References & Thank You | 45-50 | 0.5 min |
| **TOTAL** | **50** | **~32 min** |

---

*Script Version 2.0*  
*Last Updated: January 2026*  
*Based on finalized 50-slide presentation*
